Savior Lifetec Corporation (TPEX:4167)

Market Cap	6.01B
Revenue (ttm)	1.22B
Net Income (ttm)	497.38M
Shares Out	317.40M
EPS (ttm)	1.56
PE Ratio	12.14
Forward PE	n/a
Dividend	0.09 (0.45%)
Ex-Dividend Date	Jul 14, 2025

Volume	544,151
Average Volume	469,924
Open	19.00
Previous Close	18.95
Day's Range	19.00 - 19.25
52-Week Range	14.35 - 23.80
Beta	0.36
RSI	49.43
Earnings Date	Aug 8, 2025

About Splunk

Savior Lifetec Corporation, a specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations. The company provides various carbapenem generic drugs and injections, such as paliperidone palmitate, cetrorelix and ganirelix acetate, plecanatide, prucalopride succinate, and brinzolamide. It offers imipenem and cilastatin, meropenem, and ertapenem products. The company was founded in 1993 and is headquartered in Miaoli County, Taiwan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1993
• Employees: 384
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4167

Financial Performance

In 2024, Savior Lifetec's revenue was 1.22 billion, an increase of 15.91% compared to the previous year's 1.05 billion. Earnings were 182.38 million, an increase of 507.33%.